Delix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Delix Therapeutics's estimated annual revenue is currently $7.6M per year.
- Delix Therapeutics's estimated revenue per employee is $155,000
- Delix Therapeutics's total funding is $108M.
Employee Data
- Delix Therapeutics has 49 Employees.
- Delix Therapeutics grew their employee count by 7% last year.
Delix Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Director | Reveal Email/Phone |
2 | Co-Founder, Chief Innovation Officer, Head the SAB | Reveal Email/Phone |
3 | Head DMPK and Toxicology | Reveal Email/Phone |
4 | Head Corporate Strategy | Reveal Email/Phone |
5 | Head Program Management | Reveal Email/Phone |
6 | Interim VP Operations | Reveal Email/Phone |
7 | Associate Director, Computational Chemist | Reveal Email/Phone |
8 | Senior Director Pharmacology | Reveal Email/Phone |
9 | Senior Director, Neuroplasticity | Reveal Email/Phone |
10 | Associate Director, Pharmacology | Reveal Email/Phone |
Delix Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Delix Therapeutics?
$108M
Total Funding
49
Number of Employees
$7.6M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Delix Therapeutics News
2022-04-17 - Wellness: Ketamine
It works for substance abuse, PTSD and depression. But it's not a panacea. They just target the prefrontal cortex. Delix Therapeutics was...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 49 | 17% | N/A |
#2 | $8.9M | 49 | -6% | N/A |
#3 | $6.9M | 49 | -27% | N/A |
#4 | $12.9M | 49 | 11% | N/A |
#5 | $4.7M | 49 | 0% | N/A |